Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Home tDCS for the Treatment of Major Depression.

NCT: NCT07510880 · RECRUITING

NCT IDNCT07510880
StatusRECRUITING
Start Date2026-04-14
Completion2027-12-31

Brief Summary

The purpose of this multicentric randomized controlled trial is to compare the effectiveness and safety of home-based tDCS for the treatment of major depression versus tDCS treatment in a healthcare centre, and explore the effects of an accelerated home-tDCS protocol. The change in depression index at the end of treatment, measured with MADRS, will be the primary outcome.

Frequently Asked Questions

What is Home tDCS for the Treatment of Major Depression.?

Home tDCS for the Treatment of Major Depression. is a clinical trial registered under NCT07510880. Current status: RECRUITING.

What is the status of NCT07510880?

The current status of NCT07510880 (Home tDCS for the Treatment of Major Depression.) is: RECRUITING.

When did Home tDCS for the Treatment of Major Depression. start?

Home tDCS for the Treatment of Major Depression. started on 2026-04-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑